The abstract is read at the publisher; the summary is JClub's.
Hepatocyte-specific ChREBP overactivity in mice is linked to worse isoproterenol- and transverse aortic constriction–induced cardiac remodeling, while hepatocyte ChREBP loss protects.
- Why it matters: Cardiac remodeling is a key step toward heart failure, and tissue crosstalk mechanisms that could be targeted therapeutically remain insufficiently defined.
- What they did: In mice, hepatocyte ChREBP knockout or overexpression was tested in isoproterenol- or transverse aortic constriction–induced remodeling, with RNA sequencing and LC-MS/MS used to map pathways and ChREBP–SURF4 interactions. Hepatocyte ChREBP deficiency increased hepatic ApoM expression and secretion via SURF4 release, not ApoM transcription.
- The result: Liver ApoM overexpression or ApoM-containing HDL injection ameliorated cardiac remodeling through the S1P/S1PR1 pathway in the heart, supporting the hepatic ChREBP–SURF4–ApoM axis as a therapeutic target.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.